Showing 1 - 20 results of 84 for search '"health technology assessment"', query time: 0.10s Refine Results
  1. 1

    Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France by Emanuele Arcà, Dorothea Heldt, Martina Smith

    Published 2025-01-01
    “…We analysed and compared health technology assessment (HTA) criteria for DTx across European countries that had assessed the same DTx products. …”
    Get full text
    Article
  2. 2

    The epidemiological and economic burden of diabetes in Ghana: A scoping review to inform health technology assessment. by Joseph Kazibwe, Mohamed Gad, Emmanuella Abassah-Konadu, Ivy Amankwah, Richmond Owusu, Godwin Gulbi, Sergio Torres-Rueda, Brian Asare, Anna Vassall, Francis Ruiz

    Published 2024-01-01
    “…There is an urgent need for effective and efficient interventions to prevent the anticipated elevation in burden of disease through the utilisation of existing evidence and proven priority-setting tools like Health Technology Assessment (HTA).…”
    Get full text
    Article
  3. 3
  4. 4

    Medicine and the Law by S Abdool Karim

    Published 2024-09-01
    Subjects:
    Get full text
    Article
  5. 5

    Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme by Stephen J Walters, Daniel Hind, Richard M Jacques, Steven A Julious, Joanne Rothwell, Oscar Bortolami, Laura Flight, Inês Bonacho dos Anjos Henriques-Cadby, Christopher Knox, Ben Nadin, Michael Surtees

    Published 2017-03-01
    “…Many trials fail to reach their planned sample size within the envisaged trial timescale and trial funding envelope.Objectives To review the consent, recruitment and retention rates for single and multicentre randomised control trials funded and published by the UK's National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme.Data sources and study selection HTA reports of individually randomised single or multicentre RCTs published from the start of 2004 to the end of April 2016 were reviewed.Data extraction Information was extracted, relating to the trial characteristics, sample size, recruitment and retention by two independent reviewers.Main outcome measures Target sample size and whether it was achieved; recruitment rates (number of participants recruited per centre per month) and retention rates (randomised participants retained and assessed with valid primary outcome data).Results This review identified 151 individually RCTs from 787 NIHR HTA reports. …”
    Get full text
    Article
  6. 6
  7. 7

    Clinical study and Health Technology Assessment (HTA) of a Robot-Assisted Gait Training on children with neurological disorders: A quasi-experimental study by Simone GAZZELLINI, Martina ANDELLINI, Federica DE FALCO, Daniela CASASANTA, Giampietro CORDONE, Alessandra COLAZZA, Donatella LETTORI, Massimiliano RAPONI, Enrico CASTELLI, Maria Rosaria VINCI, Reparata Rosa DI PRINZIO, Maurizio PETRARCA, Matteo RITROVATO, Salvatore ZAFFINA

    Published 2023-03-01
    “…The clinical investigation was integrated with a Health Technology Assessment (HTA) study, to investigate the introduction and impact of RAGT compared to patient-centered rehabilitation techniques and identify the most relevant criteria to assess the use of robotic rehabilitation technologies. …”
    Get full text
    Article
  8. 8

    The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada by Jihyung Hong, Eun-Young Bae, Sohee Cha, Joohyun Lee

    Published 2025-01-01
    “…Data, including funding arrangements and evidence assessed, were derived from national health technology assessment (HTA) documents and other public domains in the four countries. …”
    Get full text
    Article
  9. 9

    A proposed conceptual model for orphan drug market entry by Nataša Jalen, Tina Vukasović

    Published 2024-11-01
    Subjects: “…marketing model, marketing strategy, rare disease, health technology assessment, orphan drug, grounded theory…”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20